Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Gynecol Oncol. 2021 May 3;162(1):24–31. doi: 10.1016/j.ygyno.2021.04.034

Figure 3.

Figure 3.

Kaplan-Meier curves for (A) progression-free survival (PFS) and (B) overall survival (OS) based on lenvatinib starting dosage. NR = not reached. 95% CI = 95% confidence interval.